Category Reports | ResearchPool

Almost there...

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

First Name*

Last Name*

Country*

Email*

Password* ( 6 or more alphabetic and numerical characters )

Get financial insights straight to your inbox.

YES

I have read and accept ResearchPool Terms & Conditions, and Privacy Policy, including our Cookie Use Policy

Already on ResearchPool? Login Now

Back to the main directory

Press Release

MIMEDX to Host Fourth Quarter and Full Year 2024 Operating and Financial Results Conference Call on February 26 by GlobeNewsWire
Collegium Appoints Nancy S. Lurker to its Board of Directors by GlobeNewsWire
ARS Pharmaceuticals to Participate in the Oppenheimer 35th Annual Healthcare Conference by GlobeNewsWire
Ultragenyx Announces New Data Demonstrating that Treatment with UX111 AAV Gene Therapy Significantly Improved Clinical Function Across Multiple Developmental Domains in Children with Sanfilippo Syndrome Type A (MPS IIIA) Correlated with Sustained Reductio by GlobeNewsWire
Systemic Bio Wins the SLAS 2025 Innovation Award by GlobeNewsWire
Indaptus Therapeutics Receives Approval from Health Canada to Expand Clinical Trial of Decoy20 by GlobeNewsWire
Atossa Therapeutics Congratulates Board Director Dr. Tessa Cigler and Weill Cornell Medicine on CDC Grant to Enhance Breast Cancer Care by GlobeNewsWire
Aprea Therapeutics Announces Strategic IP Portfolio Evolution in DNA Damage Response (DDR) Cancer Therapeutics by GlobeNewsWire
Vaxcyte Advances to Second Stage of Ongoing Phase 2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease in Infants by GlobeNewsWire
Twin Disc Approves a Quarterly Cash Dividend by GlobeNewsWire
Acrivon Therapeutics Announces FDA has Granted Breakthrough Device Designation for ACR-368 OncoSignature Assay for Endometrial Cancer by GlobeNewsWire
Algorhythm Holdings Announces Date and Ratio of Reverse Stock Split by GlobeNewsWire
Willis appoints Stephen Kyriacou Head of Litigation and Contingent Risk Solutions in North America by GlobeNewsWire
Brown-Forman Third Quarter Earnings Release and Conference Call Scheduled for March 5, 2025 by BusinessWire
Nearly 70% of Single People Struggle to Afford Housing Payments, Compared to 52% of Married People by BusinessWire
Oxbridge / SurancePlus Selects Coinbase Prime to Support Strategic Bitcoin and Ethereum Investment by GlobeNewsWire
Síminn hf. - Reglubundin tilkynning um kaup á eigin bréfum í samræmi við endurkaupaáætlun by GlobeNewsWire
Dassault Systèmes: declaration of the number of outstanding shares and voting rights as of January 31, 2025 by GlobeNewsWire
Navitas’ GaN & SiC Devices Power Dell’s™ Family of AI Notebooks by GlobeNewsWire
Birchtech Corp. Files Patent Infringement Lawsuit Against Major Power Utility, Evergy by GlobeNewsWire
Duolingo to Participate in Upcoming Investor Conferences by GlobeNewsWire
Fluent, Inc. Survey Finds That Shoppers Embrace Post-Purchase Ads, Citing Personalization & Relevance as Key Benefits by GlobeNewsWire
Phunware Mobile Hospitality Solution Deployed at JW Marriott Phoenix Desert Ridge Resort & Spa by GlobeNewsWire
GlobalFoundries Announces Leadership Transition to Drive Next Phase of Growth by GlobeNewsWire
374Water to Demonstrate Commercial-Scale PFAS Destruction Capabilities in Upcoming DoD ESTCP/DIU Project by GlobeNewsWire

Health Catalyst to Announce Fourth Quarter and Full Year 2024 Operating Results and Host Conference Call on Wednesday, February 26, 2025 by GlobeNewsWire
Stryker declares an $0.84 per share quarterly dividend by GlobeNewsWire
Orchestra BioMed Announces Appointment of Former Medtronic SVP of Corporate Development Christopher Cleary to Board of Directors by GlobeNewsWire
Ovid Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference by GlobeNewsWire
Annovis Announces First Patients Entered into Pivotal Phase 3 Study of Buntanetap for Early Alzheimer’s Disease by GlobeNewsWire
ITW Reports Fourth Quarter and Full Year 2024 Results by GlobeNewsWire
WillScot to Announce Fourth Quarter 2024 Results on February 20, 2025 by GlobeNewsWire
Akoya Biosciences Unveils Strategic Product Roadmap, Powered by the New IO60 and Upcoming Neurobiology Panels by GlobeNewsWire
Asia Broadband’s Nears Completion Of Its Next-Generation AABB Wallet’s On/Off Ramp To Facilitate Users to Buy and Sell the AABBG Token by GlobeNewsWire
Twin Disc Announces Second Quarter Results by GlobeNewsWire
Oxbridge / SurancePlus Selects Coinbase Prime to Support Strategic Investments in Digital Assets by GlobeNewsWire
Rezolve Ai Kicks Off 2025 with Major Retail Expansion as Leading Brands Leverage Its Cutting-Edge Technology by GlobeNewsWire
Cellectar Biosciences to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference by GlobeNewsWire
NRC Health ranked #1 Best in KLAS for Healthcare Experience Management by BusinessWire
Oragenics, Inc. Chief Medical Officer, Dr. James P. Kelly, to Participate in the 12th Annual Brain Health Summit at the Leigh Steinberg Super Bowl Party 2025 by GlobeNewsWire
IKS Health Named 2025 Best in KLAS for Medical Transcription Services for 7th Straight Year by BusinessWire
SFL - Invitation to Presentation of Q4 2024 Results by GlobeNewsWire
Dassault Systèmes : déclaration du nombre d'actions et de droits de vote au 31 janvier 2025 by GlobeNewsWire
PodcastOne (PODC) to Host Third Quarter Fiscal Year 2025 Financial Results Conference Call on Wednesday, February 12, 2025, at 11:30 a.m. Eastern Standard Time by GlobeNewsWire
Lantheus Announces Presentations Featuring PYLARIFY (Piflufolastat F 18) Data at the ASCO GU Meeting by GlobeNewsWire
Myriad Genetics and Lumea Collaborate to Enhance Access to the Prolaris Biomarker and MyRisk Hereditary Cancer Tests through BxLink Integration by GlobeNewsWire
Gain Therapeutics To Participate in Upcoming Investor Conferences by GlobeNewsWire
Giftify, Inc. Cancels Equity Line of Credit by GlobeNewsWire
Lisata Therapeutics to Present at the 2025 BIO CEO & Investor Conference by GlobeNewsWire
Swvl Appoints Ahmed Misbah as Chief Financial Officer by GlobeNewsWire

«
1
2
...
17278
17279
17280
17281
17282
17283
17284
...
18286
18287
»

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Press Release

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe